Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy diversity 4-4 (IGHD4-4) is a short gene segment within the immunoglobulin heavy chain locus (IGH) on chromosome 14. It encodes a D (diversity) region, which, through somatic recombination with variable (V) and joining (J) segments, contributes to the enormous diversity of antibody variable regions in B lymphocytes. The genomic diversity of IGHD4-4—and other immunoglobulin D segments—enables the generation of a wide range of antibodies, critical to the adaptive immune response. IGHD4-4 itself is not expressed as a protein but provides template DNA during the V(D)J recombination process in developing B cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy diversity 4-4 (IGHD4-4).